State-of-the-Art Cancer Immunotherapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

State-of-the-Art Cancer Immunotherapies

Published:2024-02-22 Issue:5 Volume:25 Page:2532
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Nagase Hisashi¹,Kato Takuma²³,Yoshimoto Takayuki⁴^ORCID

Affiliation:

1. Department of Parasitology, Shinshu University School of Medicine 3-1-1, Asahi, Matsumoto 390-8621, Japan

2. Department of Cellular and Molecular Immunology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan

3. Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan

4. Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan

Abstract

Cancer immunotherapy is a type of cancer therapy utilizing the immune system to fight against tumors [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1422-0067/25/5/2532/pdf

Reference22 articles.

1. CAR T cell immunotherapy for human cancer;June;Science,2018

2. Immune Checkpoint Inhibitors in Cancer Therapy;Shiravand;Curr. Oncol.,2022

3. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine;Polack;N. Engl. J. Med.,2020

4. Engineering cytokines for cancer immunotherapy: A systematic review;Fu;Front. Immunol.,2023

5. Li, J., Zhang, Y., Dong, P.Y., Yang, G.M., and Gurunathan, S. (2023). A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. Biomed. Pharmacother., 165.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP